论文部分内容阅读
目的:探讨儿童过敏性紫癜(HSP)的临床特点。方法:对2007年1月-2011年1月本院住院的68例过敏性紫癜患儿的发病特点、临床表现、肾损害相关因素及预后等方面进行回顾性分析。结果:经综合治疗,68例中有49例(72.59%)治愈,19例(27.94%)好转,无1例死亡。结论:对感染患者给予抗过敏、西咪替丁联合消旋山莨菪碱配合基础治疗儿童过敏性紫癜能促进紫癜消失,有益疾病控制。
Objective: To investigate the clinical features of Henoch-Schonlein purpura (HSP) in children. Methods: The incidence, clinical manifestations, related factors of renal damage and prognosis of 68 children with Henoch-Schonlein purpura hospitalized in our hospital from January 2007 to January 2011 were analyzed retrospectively. Results: After treatment, 49 cases (72.59%) were cured and 19 cases (27.94%) were cured, none of them died. CONCLUSIONS: Anti-allergy is given to infected patients, and cimetidine combined with racemic anisodamine in children with Henoch-Schonlein purpura can promote the disappearance of purpura and control the disease.